ABIVAX 90.450 € (-3,62 %)
EUTELSAT COMMUNIC. 1.815 € (+0,39 %)
KERING 238.000 € (+1,56 %)
METAVISIO 0.001 € (+8,33 %)
ASM INTERNATIONAL 771.600 € (+2,88 %)
VOPAK 48.140 € (+0,33 %)
TOTALENERGIES 80.030 € (-0,57 %)
GETLINK SE 18.560 € (+0,32 %)
DBT 0.069 € (-18,82 %)
STMICROELECTRONICS 42.605 € (+1,96 %)
RAPID NUTRITION 2.525 € (-6,48 %)
AKZO NOBEL 57.540 € (+0,42 %)
FORFARMERS 5.840 € (+2,46 %)
HERMES INTL 1 383.000 € (+0,58 %)
GTT 221.600 € (+2,21 %)
ABN AMRO BANK N.V. 43.370 € (+1,59 %)
MAGNUM 16.446 € (-1,52 %)
BNP PARIBAS ACT.A 102.320 € (+1,01 %)
PHILIPS KON 21.690 € (+0,51 %)
CROSSJECT 1.326 € (+1,22 %)
ASML HOLDING 1 396.200 € (+1,26 %)
AIRBUS 196.280 € (+0,76 %)
SHELL PLC 41.825 € (-2,05 %)
LVMH 410.950 € (+1,11 %)
ARTMARKET COM 3.840 € (+0,52 %)
ADYEN 914.700 € (-1,81 %)
BOLLORE 3.694 € (-0,32 %)
V LANSCHOT KEMPEN 68.050 € (+0,59 %)
SIGNIFY NV 14.640 € (-0,14 %)
AMUNDI 90.750 € (+0,39 %)
CELLECTIS 1.151 € (-14,74 %)
S.E.B. 55.400 € (-0,63 %)
JCDECAUX 24.380 € (-0,57 %)
ERAMET 43.000 € (-1,29 %)
KAUFMAN ET BROAD 21.700 € (+0,93 %)
ALSTOM 15.765 € (+0,90 %)
NRJ GROUP 6.160 € (-0,32 %)
SOCIETE GENERALE 73.670 € (+1,25 %)
SPIE 44.500 € (+1,55 %)
CSG 15.792 € (-0,79 %)
ATOS GROUP 25.540 € (+1,43 %)
THX PHARMA 3.260 € (+0,62 %)
ADP 107.200 € (-1,29 %)
EURONEXT 157.200 € (-0,44 %)
RELX 29.800 € (0,00 %)
BE SEMICONDUCTOR 178.850 € (+1,42 %)
NETGEM 1.000 € (-3,85 %)
CRCAM ATL.VEND.CCI 133.600 € (-4,00 %)
SOITEC 139.500 € (+13,41 %)
DSM FIRMENICH AG 91.780 € (+0,20 %)
SANOFI 74.350 € (+0,19 %)
PUBLICIS GROUPE SA 97.040 € (-1,78 %)
PULLUP ENTERTAIN 8.440 € (+2,18 %)
PLUXEE 15.040 € (+0,27 %)
GENSIGHT BIOLOGICS 0.111 € (-5,77 %)
VOYAGEURS DU MONDE 179.000 € (0,00 %)
RANDSTAD NV 36.800 € (-1,47 %)
DIAGNOSTIC MEDICAL 1.120 € (+1,82 %)
THERACLION 0.663 € (+3,59 %)
POUJOULAT 5.900 € (-4,53 %) |
18/06/2026 17:45
2CRSi SA: 2CRSi disputes the content of the document published by Grizzly Research and is preparing a substantiated response calling for the suspension of trading in its sharesHigh performance serversPress Release 2CRSi disputes the content of the document published by Grizzly Research and is preparing a substantiated response calling for the suspension of trading in its sharesStrasbourg, France – 18/06/2026 – 2CRSi (ISIN: FR0013341781), a designer and manufacturer of high-performance, energy-efficient servers, has taken note of the report published by Grizzly Research LLC containing serious allegations concerning the Company, which it strongly refutes. In the interests of transparency, rigour and equal access to information, the Company announces that it has requested Euronext to suspend trading in its shares, in order to provide a detailed response to the allegations made in the report and to enable the market to have all the necessary information for assessment. To this end, the Board of Directors of 2CRSi has referred the matter to its Audit and Risk Committee. 2CRSi will communicate with the market as soon as possible, in accordance with its regulatory obligations. 2CRSi also reserves the right to take any action it deems appropriate to protect its rights, its reputation and the interests of its shareholders. About 2CRSiFounded in 2005 in Strasbourg (France), 2CRSi designs, develops, and manufactures high-performance computer servers and innovative solutions for Artificial Intelligence, high-performance computing, and data storage. Committed to a responsible and sustainable approach, the group operates across multiple continents and delivers energy-efficient technological solutions to sectors including tech, industry, gaming, scientific research, and datacenters. 2CRSi has been listed since June 2018 on the Euronext Paris regulated market (ISIN code: FR0013341781) and transferred to Euronext Growth in November 2022. Learn more at https://2crsi.com/ Contacts 2CRSi
Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière